Search results
Why the GLP-1 impact on other industries 'will take years'
Yahoo Finance· 1 day agoThis larger population scenario assumes more cost and impact to the system and to industries. But...
Gateway - Quartz
Quartz· 1 day agoDanish pharma giant Novo Nordisk, the maker of the popular diabetes and weight loss drugs Ozempic and Wegovy, has a prominent admirer in its home country. Denmark’s Prime ...
Drugmaker to testify on why weight-loss drugs cost 15x more in the US
Ars Technica· 2 days agoAfter some persuasion from Sen. Bernie Sanders (I-Vt.), the CEO of Novo Nordisk will testify before...
Top doctor warns against taking weight loss drugs such as Ozempic to get 'beach body ready' for...
Business Insider· 4 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
Second Chinese drugmaker seeks approval for Ozempic generic
Reuters· 5 days ago, opens new tab said this week its subsidiary was seeking approval to sell the drug to control blood...
Sen. Sanders calls off subpoena vote over maker of Ozempic and Wegovy
BenefitsPRO· 5 days agoSanders, the chairman of the Senate Health, Education, Labor and Pensions Committee, had announced...
Texas patients turn to clinics for compounded semaglutide with Ozempic and WeGovy scarce | Texarkana...
Texarkana Gazette· 2 days agoWhen working out, dieting and even turning to other medications didn't help, she decided to try...
Sanders drops Novo Nordisk subpoena threat
Becker’s Hospital Review· 3 days agoVermont Sen. Bernie Sanders has canceled a Senate committee vote that would have determined whether to subpoena Novo Nordisk executives about the cost of the drugmaker's blockbuster ...
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy By Reuters
Investing.com· 5 days agoA U.S. Senate health panel vote that was scheduled for its June 18 meeting, to decide whether to...
Saxenda injections for weight loss: Side effects and benefits
The Telegraph via Yahoo News· 2 days agoInterest in the weight loss drug Saxenda has skyrocketed. According to Google Trends, searches have...